novel

HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great startHarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

Prajakta Koli's debut romance novel, Too Good to Be True,is making waves within a few hours of its pre-order going…

4 months ago
Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to RavulizumabNovel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab

Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab

Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease…

4 months ago
HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great startHarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

Prajakta Koli's debut romance novel, Too Good to Be True,is making waves within a few hours of its pre-order going…

4 months ago
HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great startHarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

Prajakta Koli's debut romance novel, Too Good to Be True,is making waves within a few hours of its pre-order going…

4 months ago
HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great startHarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

Prajakta Koli's debut romance novel, Too Good to Be True,is making waves within a few hours of its pre-order going…

4 months ago
HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great startHarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

Prajakta Koli's debut romance novel, Too Good to Be True,is making waves within a few hours of its pre-order going…

4 months ago
HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great startHarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

Prajakta Koli's debut romance novel, Too Good to Be True,is making waves within a few hours of its pre-order going…

4 months ago
AlveoGene Receives Rare Pediatric Disease Designation (RPDD)from FDA for AVG-002, its Novel, Inhaled Gene Therapy forLethal Neonatal Surfactant Protein B (SP-B) DeficiencyAlveoGene Receives Rare Pediatric Disease Designation (RPDD)from FDA for AVG-002, its Novel, Inhaled Gene Therapy forLethal Neonatal Surfactant Protein B (SP-B) Deficiency

AlveoGene Receives Rare Pediatric Disease Designation (RPDD)from FDA for AVG-002, its Novel, Inhaled Gene Therapy forLethal Neonatal Surfactant Protein B (SP-B) Deficiency

Inherited SP-B deficiency is an ultra-rare monogenic cause of fatal respiratory distress syndrome in newborn infantsClinical estimates for SP-B deficiency…

5 months ago
SoldierStrong to Support Veterans with Novel Immersive Healthcare TechnologySoldierStrong to Support Veterans with Novel Immersive Healthcare Technology

SoldierStrong to Support Veterans with Novel Immersive Healthcare Technology

November 14, 2024 09:00 ET | Source: SoldierStrong SoldierStrong to support the physical rehabilitation of the men and women of…

5 months ago
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual MeetingCompass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

New data showed a correlation between the levels of neural cell adhesion molecule (NCAM or CD56) expression and response and…

5 months ago
Show more Posts
Show previous Posts